Kato R, Solanki HS, Ozakinci H, Desai B, et al. In situ RAS:RAF binding correlates with response to KRASG12C inhibitors in KRASG12C--mutant non-small cell lung cancer. Clin Cancer Res 2025 Jan 21. doi: 10.1158/1078-0432.CCR-24-3714.
PMID: 39836411